CURE Magazine

4 days ago | curetoday.com | Laura Yeager

It was 1997. I was 34 and 140 pounds. I would be getting married in a few months, and we were interviewing photographers. We found one in the classified section of a local newspaper. His name was Lew. I remember he came to my mother’s house, where I was living. The one thing I remember about him is that he had puffy hair. Turns out, he was also a hairdresser. He owned a salon in Akron.

1 week ago | curetoday.com | Ariana Pelosci

Among patients with EGFR-mutated non–small cell lung cancer (NSCLC), Rybrevant (amivantamab-vmjw) plus chemotherapy improved efficacy compared with chemotherapy alone according to results from the phase 3 MARIPOSA-2 trial assessing Tagrisso (osimertinib) resistance mechanisms, as presented at the 2025 American Society of Clinical Oncology Annual Meeting.

2 weeks ago | curetoday.com | Diana Martin

There have been many studies that tout the usefulness of journaling on a daily basis to help with healing. As a writer, I found great difficulty trying to put pen to paper during my husband’s struggle with bile duct cancer that took his life in 2015. I much preferred to teach, sleep, care for him, eat, or do anything but write. Perhaps the emotions were too difficult to put into words. Or maybe I was not ready. Either way, years after his death, I’m able to write about this experience.

2 weeks ago | curetoday.com | Brenda Denzler

Dear Brenda,You’ve just been diagnosed with inflammatory breast cancer, and I know you’re scared to death. You have every right to be. Not only are you facing a very aggressive, low-survival form of breast cancer, but you’re being forced to deal with a medical profession that traumatized you repeatedly with their treatments and neglect when you were deathly ill as a very young child. That experience left deep scars upon your psyche that you are only beginning to see.

2 weeks ago | curetoday.com | Kristie Kahl

It is crucial to understand the characteristics of the disease following a diagnosis of metastatic breast cancer, especially the cancers subtypes and associated biomarkers, as these directly impact the direction of treatment decisions. Moreover, advancements in treatment strategies within the therapeutic landscape aims to manage disease, control progression, as well as maintain quality of life for patients.